NBP Stock Analysis: Buy, Sell, or Hold?
$1.84
-0.05 (-2.65%)
âŧ
5d:
-8.0%
30d:
+12.2%
90d:
+0.0%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 19, 2026
0d
Get Alerted When NBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NBP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NBP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NBP is currently trading at $1.84, which is considered fair relative to its 30-day fair value range of $1.69 to $1.92.
Technical Outlook: Technically, NBP is in a downtrend. Immediate support is located at $1.78, while resistance sits at $2.02.
Market Sentiment: NBP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.00 (+334.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBP is in a downtrend. Immediate support is located at $1.78, while resistance sits at $2.02.
Market Sentiment: NBP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.00 (+334.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.69 -
$1.92
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 334.8% below Wall St target ($8.00)
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.69 -
$1.92
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.78
Resistance Level
$2.02
Current Trend
Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.74
Wall Street Target
$8.00
(+334.8%)
Share & Embed Analysis
Last updated: August 29, 2026 7:46 AM ET
Data refreshes hourly during market hours. Next update: 8:46 AM
Data refreshes hourly during market hours. Next update: 8:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 48 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 36 SELL |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$27 | 48 HOLD |